The future of
diabetes care.

For more than 30 years, Medtronic has been providing personalized diabetes solutions and support. We continue to push the boundaries for tomorrow. We are investing in the development of new products so that we can continue to lead and innovate in diabetes technology.

Live More.
Worry Less.

Our goal for the future is to develop technology so that those living with diabetes can live more and worry less.

  • Imagine a future where...
    It would be okay to forget taking your insulin at mealtime.

    We are working on advanced predictive analytics that aim to help you stay in glucose control without having to be perfect all the time.

    Imagine less mental math. More actual living

  • Imagine a future where...
    Counting carbs may be a thing of the past.

    We are developing advanced prediction and detection algorithms that strive to lessen the stress and worry about food.

    You could worry less about mealtime insulin

  • Imagine a future where...
    The most advanced diabetes management tools are delivered to the palm of your hand.

    We are creating connectivity options that aim to bring you the latest technologies with the push of a button.

    In the future, smart phones could be smarter at managing your diabetes

  • Imagine a future where...
    You could get a system that does more of the thinking for you.

    We are engineering smart systems that aim to adapt to your behaviors and your lifestyle so that you have one less thing to worry about.

    Tech that could help better predict your glucose for your unpredictable life

  • Thanks for learning about our future products. For information about our currently available product solutions, click here.


Potential future technology. Not approved by the FDA and not commercially available. Features and performance of any future technologies may vary.
OUR SOLUTIONS FOR TODAY

Start your journey with Medtronic today.


For information about our solutions that are currently available, complete the form or call today at 888-680-2280 (M-F 9AM-6PM CST)

Are you an existing Medtronic Diabetes customer?

Select one or more of the below:

AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

You authorize Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes or its subsidiaries, contractors or representatives to use your personal information, including but not limited to your contact information and health information, for marketing purposes and to share that information with Medtronic representatives and contractors. Information you may receive includes, but is not limited to: (a) Medtronic Diabetes products, therapies or services; (b) marketing and promotional offers; (c) inquiries about your experience with Medtronic Diabetes products, therapies and services; and/or (d) suggestions for how Medtronic Diabetes can enhance its customer support.

This authorization will expire three (3) years from the later of the date you submit this authorization online; or (ii) the last date products or services were received from Medtronic, but may expire sooner if you revoke it by following the instructions below.

You have the right to revoke this authorization at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating my communication preferences at www.diabetes.shop/myhome. A revocation will not affect actions Medtronic Diabetes has already taken based on this authorization. Information disclosed pursuant to this authorization may be re-disclosed by the recipient of the information and may no longer be protected by the federal privacy standards.

You have the right to refuse to sign this authorization. Refusal to sign will not affect your treatment or health insurance eligibility or benefits.

Questions? Contact our Customer Service Center at 800-646-4633, or by email at takecontrol@medtronic.com.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

Products that help you worry less about your diabetes.

Helps you plan ahead so you can focus on your life, not your sugar levels.


Guardian™ Connect System
Guardian™ Connect System
Guardian™ Connect System
Guardian™ Connect System
Guardian™ Connect System
Guardian™ Connect System

Guardian™ Connect System

You and your loved ones can now track your glucose levels on your phone with our continuous glucose monitoring (CGM) system.

Customize your alerts to fit your lifestyle.
Learn how your body reacts to certain foods and insulin.

REQUEST MORE INFORMATION 30 day trial offer


Available for people with type 1 and type 2 diabetes.

Automatically adjusts insulin to help stop you from going low.


MiniMed™ 670G System

Experience insulin pump technology that adapts to your body’s unique needs.Δ

Take advantage of advanced technology that optimizes your background insulin levels.

REQUEST MORE INFORMATION Promotion available


Available for people with type 1 diabetes.
For people with type 2 diabetes, we have the MiniMed™ 630G system available. Complete the form below or call for more information.

Helping those with type 2 diabetes better manage your levels.


MiniMed™ 630G System
MiniMed™ 630G System
MiniMed™ 630G System
MiniMed™ 630G System
MiniMed™ 630G System
MiniMed™ 670G System

MiniMed™ 630G System

Allowing you to more easily deliver your insulin than multiple daily injections.

Fewer injections for your background insulin and meal boluses.*

REQUEST MORE INFORMATION Try it for 30 days


Available for people with type 1 or type 2 diabetes who use insulin.

Start your journey with Medtronic today.


To find out more about current products and estimated out-of-pocket costs, complete the form or call today at 888-680-2280 (M-F 9AM-6PM CST)

Are you an existing Medtronic Diabetes customer?

Select one or more of the below:

AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

You authorize Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes or its subsidiaries, contractors or representatives to use your personal information, including but not limited to your contact information and health information, for marketing purposes and to share that information with Medtronic representatives and contractors. Information you may receive includes, but is not limited to: (a) Medtronic Diabetes products, therapies or services; (b) marketing and promotional offers; (c) inquiries about your experience with Medtronic Diabetes products, therapies and services; and/or (d) suggestions for how Medtronic Diabetes can enhance its customer support.

This authorization will expire three (3) years from the later of the date you submit this authorization online; or (ii) the last date products or services were received from Medtronic, but may expire sooner if you revoke it by following the instructions below.

You have the right to revoke this authorization at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating my communication preferences at www.diabetes.shop/myhome. A revocation will not affect actions Medtronic Diabetes has already taken based on this authorization. Information disclosed pursuant to this authorization may be re-disclosed by the recipient of the information and may no longer be protected by the federal privacy standards.

You have the right to refuse to sign this authorization. Refusal to sign will not affect your treatment or health insurance eligibility or benefits.

Questions? Contact our Customer Service Center at 800-646-4633, or by email at takecontrol@medtronic.com.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

  • Julie's Story

    Diabetes doesn't have to stop Julie from shredding the slopes. With the MiniMed™ 670G system, she can spend her time telemark skiing while worrying less about her diabetes!Φ

    Watch video

  • Gina's Story

    "The adaptive algorithm of the MiniMed™ 670G system relieves a great deal of my diabetes management burden."Δ,Φ

    Read story

  • Nalani's Story

    "Starting on the system was the first time since I can remember that I have been able to sleep through the night."Φ

    Read story

Φ The patient testimonial above relates an account of an individual’s response to treatment. The account is genuine, typical and documented. However, this patient’s response does not provide any indication, guide, warranty or guarantee as to the response other people may have to the treatment. The response other individuals have to the treatment could be different. Responses to the treatment can and do vary. Not every response is the same. Please talk to your doctor about your condition and the risks and benefits of these technologies.
Julie was provided product in exchange for her own thoughts and opinions. Individual results may vary. She is also an Ambassador of Medtronic.
Gina is an employee of Medtronic. Her thoughts and opinions are her own.

Δ Refers to Auto Mode. Some user interaction required. Individual results may vary.
* Assumes four injections per day for 30 days and one infusion set change every two to three days.
† The Guardian™ Sensor 3 glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required.
†† The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.
1. Mueckler, JR et al. Real-World Assessment of Former MDI Patients’ Experience on the Medtronic MiniMed™ 670G Hybrid Closed-Loop System (n=47). Poster presented at the 11th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD); 2017 February 14-17, Vienna, Austria.
2. Individual results may vary. Refers to Auto Mode. Gopalakrishnan S, Mueckler J, Fogel C. The MiniMed™ 670G Hybrid Closed Loop System & Patient Reported Outcomes Concerning Quality of Life Measures (n=2,534). Poster #963-P presented at the 78th Scientific Sessions of the American Diabetes Association; 2018 June 22-26, Orlando, Florida, USA.
3. Reznik Y, Cohen O, Aronson R, et al.; OpT2mise Study Group, Insulin pump treatment comparewith multiple daily injections for the treatment of type 2 diabetes (OpT2mise): a randomized open label controlled trial. Lancet. 2014; 384(9950): 1265-1272.
4. Aronson R, Reznik Y, Conget I, et al. Sustained efficacy of insulin pump therapy, compared with multiple daily injections, in type 2 diabetes: 12-month data from the OpT2mise randomized trial. Diabetes Obesity and Meta. 2016; 18:500-507.

MINIMED™ 670G SYSTEM
The Medtronic MiniMed™ 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, seven years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 670G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian™ Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an Alternative Site (palm) or from a control solution test. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode.

WARNING: Medtronic performed an evaluation of the MiniMed™ 670G system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin dose of 8 units per day because the device requires a minimum of 8 units per day to operate safely.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 670G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-670g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library

MINIMED™ 630G SYSTEM WITH SMARTGUARD™ TECHNOLOGY
Indicated for the continuous delivery of insulin, at set and variable rates, for the management of diabetes mellitus. MiniMed™ 630G system is approved for ages 14 years or older with Guardian™ Sensor 3 and MiniMed™ 630G system is approved for ages 16 years or older with Enlite™ sensor. Both systems require a prescription. Insulin infusion pumps and associated components of insulin infusion systems are limited to sale by or on the order of a physician and should only be used under the direction of a healthcare professional familiar with the risks of insulin pump therapy. Pump therapy is not recommended for people who are unwilling or unable to perform a minimum of four blood glucose tests per day. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Insulin pumps use rapid-acting insulin. If your insulin delivery is interrupted for any reason, you must be prepared to replace the missed insulin immediately. Replace the infusion set every 48–72 hours, or more frequently per your healthcare professional’s instructions. Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected. The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a blood glucose meter. A confirmatory fingerstick using a CONTOUR®NEXT LINK 2.4 meter is required prior to making adjustments to diabetes therapy. Always check the pump display when using a CONTOUR®NEXT LINK 2.4 meter, to ensure the glucose result shown agrees with the glucose results shown on the meter. Do not calibrate your CGM device or calculate a bolus using a result taken from an Alternative Site (palm) or a result from a control solution test. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. The MiniMed™ 630G system is not intended to be used directly for preventing or treating hypoglycemia but to suspend insulin delivery when the user is unable to respond to the Suspend on low alarm and take measures to prevent or treat hypoglycemia themselves. Therapy to prevent or treat hypoglycemia should be administered according to the recommendations of the user’s healthcare provider.

WARNING: The SmartGuard™ Suspend on low feature will cause the pump to temporarily suspend insulin delivery for two hours when the sensor glucose reaches a set threshold. Under some conditions of use the pump can suspend again, resulting in very limited insulin delivery. Prolonged suspension can increase the risk of serious hyperglycemia, ketosis, and ketoacidosis. Before using the SmartGuard™ feature, it is important to read the SmartGuard™ feature information in the User Guide and discuss proper use of the feature with your healthcare provider.

See Important Safety Information and the appropriate user guides for additional important details.

GUARDIAN™ CONNECT SYSTEM
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings in place for accurate operation. A nonfunctioning mobile device or incorrect settings may prevent the app from issuing alerts. Missing alerts may result in undetected low and high glucose levels. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and Important Safety Information.

940M21069-011 09SEP2019 © Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

Ascensia Diabetes Care

Ascensia, the Ascensia Diabetes Care logo, and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care.

With Watson is a trademark of International Business Machines Corporation, registered in many jurisdictions worldwide.


Top of page
Notice of Privacy Practices
Terms of Use Website
Privacy Policy

Real-life stories.

Hundreds of thousands of people who live with diabetes are using Medtronic technology today. Hear how our devices are helping them live more and worry less.

Featured videos

  • Dirt Bikes and Diabetes: Nalani’s Story

    Nalani is a Physician Assistant who loves dirt biking, hiking, archery, and so much more. Hear her story about living life with diabetes and the MiniMed™ 670G system.Φ

    Watch video

  • Diabetes is No Longer a Huge Boulder:
    Dr. McVean’s Story

    Hear how the MiniMed™ 670G system is helping Dr. Jennifer McVean worry a little bit less about diabetes.Φ

    Watch video

  • A Thousand Doors Have Been Opened: Luke’s Story

    Luke is a drummer, bike rider, travel enthusiast, and has type 1 diabetes. Hear his story about his diabetes journey.Φ

    Watch video

  • Mason's Story

    Mason, a 9-year-old boy, and his mother, Karen, share their incredible type 1 diabetes journey and talk about how the MiniMed™ 670G system has changed their lives for the better.

    Watch video

  • Ambar's Story

    Ambar has type 1 diabetes. But it doesn’t define her. Hear her share her story about the MiniMed™ 670G system and how it’s helped her.

    Watch video

  • Sage's Story

    Sage transitioned to the MiniMed™ 670G system so she could worry less about her diabetes management and focus more on her Olympic training. Hear her story.

    Watch video

Featured Stories

A busy flight attendant and bride to be - Mandy's story

A busy flight attendant and bride to be - Mandy's storyΦ

A wedding with diabetes - Gina's story

A wedding with diabetes - Gina's storyΦ

Living with diabetes since 8 years old - Nalani's story

Living with diabetes since 8 years old - Nalani's storyΦ

Diabetes and celiac disease – Cara’s story

Diabetes and celiac disease – Cara’s storyΦ

Diagnosed with type 1 diabetes at age 3 – Cory’s story

Diagnosed with type 1 diabetes at age 3 – Cory’s storyΦ

Transitioning to the MiniMed™ 670G system – Karen’s story

Transitioning to the MiniMed™ 670G system – Karen’s storyΦ

Marathon running with type 1 diabetes – Whitney’s story

Marathon running with type 1 diabetes – Whitney’s storyΦ

Trusting a device to manage my diabetes – Phyllis’ story

Trusting a device to manage my diabetes – Phyllis’ storyΦ

Diabetes camps for kids – Phyllis’ story

Diabetes camps for kids – Phyllis’ storyΦ

Start your journey with Medtronic today.


For more information about our solutions that are currently available, complete the form or call today at 888-680-2280 (M-F 9AM-6PM CST)

Are you an existing Medtronic Diabetes customer?

Select one or more of the below:

AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

You authorize Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes or its subsidiaries, contractors or representatives to use your personal information, including but not limited to your contact information and health information, for marketing purposes and to share that information with Medtronic representatives and contractors. Information you may receive includes, but is not limited to: (a) Medtronic Diabetes products, therapies or services; (b) marketing and promotional offers; (c) inquiries about your experience with Medtronic Diabetes products, therapies and services; and/or (d) suggestions for how Medtronic Diabetes can enhance its customer support.

This authorization will expire three (3) years from the later of the date you submit this authorization online; or (ii) the last date products or services were received from Medtronic, but may expire sooner if you revoke it by following the instructions below.

You have the right to revoke this authorization at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating my communication preferences at www.diabetes.shop/myhome. A revocation will not affect actions Medtronic Diabetes has already taken based on this authorization. Information disclosed pursuant to this authorization may be re-disclosed by the recipient of the information and may no longer be protected by the federal privacy standards.

You have the right to refuse to sign this authorization. Refusal to sign will not affect your treatment or health insurance eligibility or benefits.

Questions? Contact our Customer Service Center at 800-646-4633, or by email at takecontrol@medtronic.com.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

Connect with a Medtronic Ambassador


Connect

Learn more about
insulin pump therapy


learn more

Learn more about continuous glucose monitoring


learn more

Φ The patient testimonial above relates an account of an individual’s response to treatment. The account is genuine, typical and documented. However, this patient’s response does not provide any indication, guide, warranty or guarantee as to the response other people may have to the treatment. The response other individuals have to the treatment could be different. Responses to the treatment can and do vary. Not every response is the same. Please talk to your doctor about your condition and the risks and benefits of these technologies.

Addie, Cory and Nikhita were all compensated previously for spending the day with us and allowing us to photograph/videotape them. Their thoughts and opinions are their own.

Addie, Cara, Karen, Whitney, Phyllis and Nikhita were provided product in exchange for their own thoughts and opinions. Individual results may vary.

Gina is an employee of Medtronic. Her thoughts and opinions are her own.

Addie, Cara, Cory, Karen, Phyllis and Nikhita are Ambassadors of Medtronic.

940M21069-011 09SEP2019 © Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company.

Top of page
Notice of Privacy Practices
Terms of Use Website
Privacy Policy